Posaconazole API

Name	Posaconazole
Chinese name	泊沙康唑
Cas Number	171228-49-2
Source	India
Qualifications	USDMF/-/-/-/-

Posaconazole was developed by Merck and was first approved by the European Medicines Agency (EMA) on October 25, 2005. It has been approved in more than 70 countries and regions around the world, and in more than 40 countries including the United States and the European Union. Listed in countries and regions. This product is an anti-fungal infection drug that works by inhibiting the synthesis of fungal sterols. It is mainly used to treat intractable or other drug-resistant fungal infections. Compared with other antifungal drugs, tacrolimus can also penetrate the blood-brain barrier and has a higher bioavailability in the brain. This product was recommended in the 2013 China "Diagnostic Criteria and Principles of Treatment of Invasive Mycosis in Patients with Hematological Diseases/Malignant Tumors (Fourth Revised Edition)" and multinational antifungal guidelines for clinical treatment of antifungal infections.

Hot Tags: posaconazole api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Ulipristal Acetate API, Temozolomide API, Perindopril Arginine API, Rasagiline Mesylate API, Vardenafil API, Lurasidone Hydrochloride API

• Previous: Acatadine API
• Next: Trifluridine API